🔬 Latest Pharma Industry Updates

🔬 Latest Pharma Industry Updates

Home
Archive
About
🔬 Latest pharma industry updates 👇
🚀 Abivax’s oral obefazimod hits Phase III ulcerative colitis remission; stock skyrockets +500 % and raises $650M.
 • 
Nicolas Schmitz
🔬 Latest pharma industry updates 👇
Re-sending the latest edition as it seems a lot of subscribers haven't received it.
 • 
Nicolas Schmitz
🔬 Latest pharma industry updates 👇
🤝 Merck acquires Verona Pharma for $10 B, adding a first-in-class inhaled PDE3/4 inhibitor ensifentrine for COPD maintenance therapy.
 • 
Nicolas Schmitz
🔬 Latest pharma industry updates 👇
🤝 AbbVie buys Capstan Therapeutics for up to $2.1 B, gaining early autoimmune CAR-T CPTX2309.
 • 
Nicolas Schmitz

June 2025

Monthly Pharma updates - June 2025 🔔
Dear readers, so glad to introduce this new format to continue my mission of enabling information-sharing within our fantastic industry.
 • 
Nicolas Schmitz
🔬 Latest pharma industry updates 👇
🏛️ FDA removes restrictions on CAR-T therapies, removing several onerous requirements and loosening restrictions on which facilities can provide…
 • 
Nicolas Schmitz
📊 Top Mid-sized Pharma by cash available 👇
As financing becomes more difficult to obtain and macroeconomic signals create more uncertainties, I wanted to highlight with this graph public…
 • 
Nicolas Schmitz
🔬 Latest pharma industry updates 👇
😶 Departure of 2 FDA CBER leaders Nicole Verdun and Rachael Anatol dives uncertainty over future gene therapy oversight and approval pathways.
 • 
Nicolas Schmitz
🔬 Latest pharma industry updates 👇
🤝 BioNTech SE acquires rival CureVac for $1.25B, settling patent litigations, and forming a German mRNA powerhouse.
 • 
Nicolas Schmitz
🔬 Latest pharma industry updates 👇
📉 Biotech funding drops 57% in May amid concerns over Trump administration’s policies impacting drug research and regulatory agencies.
 • 
Nicolas Schmitz
🔬 Latest pharma industry updates 👇
🤝 Sanofi acquires lupus treatment DR-0201 from Dren Bio, Inc. ($1.9B total potential, $600M upfront).
 • 
Nicolas Schmitz

May 2025

© 2025 Nicolas Schmitz
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture